These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 17500)

  • 1. Methadone maintenance: effect of urinary pH on renal clearance in chronic high and low doses.
    Bellward GD; Warren PM; Howald W; Axelson JE; Abbott FS
    Clin Pharmacol Ther; 1977 Jul; 22(1):92-9. PubMed ID: 17500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Steady-state pharmacokinetics of methadone maintenance patients: renal clearance in low vs high dosages.
    Bellward GD
    Proc West Pharmacol Soc; 1977; 20():483-5. PubMed ID: 19769
    [No Abstract]   [Full Text] [Related]  

  • 3. The secretion of methadone and its major metabolite in the gastric juice of humans: comparison with blood and salivary concentrations.
    Lynn RK; Olsen GD; Leger RM; Gordon WP; Smith RG; Gerber N
    Drug Metab Dispos; 1976; 4(5):504-9. PubMed ID: 10151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methadone disposition in patients with chronic liver disease.
    Novick DM; Kreek MJ; Fanizza AM; Yancovitz SR; Gelb AM; Stenger RJ
    Clin Pharmacol Ther; 1981 Sep; 30(3):353-62. PubMed ID: 7273599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacokinetics of methadone.
    Nilsson MI; Meresaar U; Anggård E
    Acta Anaesthesiol Scand Suppl; 1982; 74():66-9. PubMed ID: 6953740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of urinary pH on the disposition of methadone in man.
    Nilsson MI; Widerlöv E; Meresaar U; Anggård E
    Eur J Clin Pharmacol; 1982; 22(4):337-42. PubMed ID: 6286317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary metabolites of dl-methadone in maintenance subjects.
    Sullivan HR; Due SL
    J Med Chem; 1973 Aug; 16(8):909-13. PubMed ID: 4745834
    [No Abstract]   [Full Text] [Related]  

  • 8. Disposition of methadone in man after a single oral dose.
    Inturrisi CE; Verebely K
    Clin Pharmacol Ther; 1972; 13(6):923-30. PubMed ID: 5081605
    [No Abstract]   [Full Text] [Related]  

  • 9. Disposition of methadone in methadone maintenance.
    Anggård E; Gunne LM; Homstrand J; McMahon RE; Sandberg CG; Sullivan HR
    Clin Pharmacol Ther; 1975 Mar; 17(3):258-66. PubMed ID: 1120392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose morphine and methadone in cancer patients. Clinical pharmacokinetic considerations of oral treatment.
    Säwe J
    Clin Pharmacokinet; 1986; 11(2):87-106. PubMed ID: 3514045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered methadone pharmacokinetics in methadone-maintained pregnant women.
    Pond SM; Kreek MJ; Tong TG; Raghunath J; Benowitz NL
    J Pharmacol Exp Ther; 1985 Apr; 233(1):1-6. PubMed ID: 3981450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of severe alcoholic liver disease on the disposition of methadone in maintenance patients.
    Novick DM; Kreek MJ; Arns PA; Lau LL; Yancovitz SR; Gelb AM
    Alcohol Clin Exp Res; 1985; 9(4):349-54. PubMed ID: 3901806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cocaine abuse in methadone maintenance patients is associated with low serum methadone concentrations.
    Tennant F; Shannon J
    J Addict Dis; 1995; 14(1):67-74. PubMed ID: 7632748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of methadone during maintenance treatment: adaptive changes during the induction phase.
    Nilsson MI; Anggård E; Holmstrand J; Gunne LM
    Eur J Clin Pharmacol; 1982; 22(4):343-9. PubMed ID: 7106170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver damage indices as a tool for modifying methadone maintenance treatment: a cross-sectional study.
    Ključević Ž; Benzon B; Ključević N; Veršić Bratinčević M; Sutlović D
    Croat Med J; 2018 Dec; 59(6):298-306. PubMed ID: 30610772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methadone-disulfiram interaction during methadone maintenance.
    Tong TG; Benowitz NL; Kreek MJ
    J Clin Pharmacol; 1980; 20(8-9):506-13. PubMed ID: 7430415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utilization of plasma and urine methadone concentrations to optimize treatment in maintenance clinics: I. Measurement techniques for a clinical setting.
    Kell MJ
    J Addict Dis; 1994; 13(1):5-26. PubMed ID: 8018740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of methadone in methadone maintenance treatment: characterization of therapeutic failures.
    Nilsson MI; Grönbladh L; Widerlöv E; Anggård E
    Eur J Clin Pharmacol; 1983; 25(4):497-501. PubMed ID: 6653644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship of pharmacokinetics to pharmacological activity: morphine, methadone and naloxone.
    Berkowitz BA
    Clin Pharmacokinet; 1976; 1(3):219-30. PubMed ID: 13957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma and urine levels of methadone. Comparison following four medication forms used in chronic maintenance treatment.
    Kreek MJ
    N Y State J Med; 1973 Dec; 73(23):2773-7. PubMed ID: 4520357
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.